Skip to main content
Log in

Therapeutic exploration of betulinic acid in chemically induced hypothyroidism

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Hypothyroidism is a chronic condition characterized by abnormally low thyroid hormone production. The decreased serum level (>5.1 mIU/l) of thyroid-stimulating hormone (TSH) in blood indicates hypothyroidism. The study was an attempt to access the effect of betulinic acid on chemically induced hypothyroidism in female albino rats. Betulinic acid is a naturally occurring pentacyclic triterpenoid, which has antiretroviral, antimalarial, and anti-inflammatory properties, as well as anticancer potential, by inhibiting topoisomerase. Hypothyroidism was induced in female albino rats using propylthiouracil (PTU) at a dose of 60 μg/kg body weight orally for 1 month. Induction of hypothyroidism was confirmed by increased TSH level. At the end of second month, blood was collected, centrifuged and serum was analyzed for TSH, T3, and T4 level and protocol was terminated by killing of animals. The animals exposed to PTU were treated with pure standard drug thyroxine at a dose of 10 μg/kg of body weight by oral route and the test drug betulinic acid 20 mg/kg by oral route through force feeding in their respective groups. Treatment was carried out for a period of 2 months. Group with PTU-induced hypothyroidism showed an elevation in serum TSH and reduction level, which was restored by the betulinic acid in treated female albino rats. Betulinic acid also reduced the damage caused in the thyroid tissues by PTU, thus minimizing the symptoms of hypothyroidism. Histopathological examinations of the thyroid tissue showed changes in the thyrocytes of PTU-treated group while thyroxine group showed normal thyroid follicles cell architecture and the group treated with betulinic acid also showed marked improvement in the follicles integrity which shows that betulinic acid has some protective activity. This study shows that the betulinic acid has thyroid-enhancing potential by lowering down the TSH levels and reducing the damage caused in the thyroid tissues, thus minimizing the symptoms of hypothyroidism when used anaphylactically in rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Almandoz JP, Gharib H (2012) Hypothyroidism: etiology, diagnosis and management. Med Clin North Am 96:203–221

    Article  CAS  PubMed  Google Scholar 

  2. Ahmed OM, El-Gareib AW, El-bakry AM, El-Tawab SMA, Ahmed RG (2008) Thyroid hormones states and brain development interactions. Int J Dev Neurosci 26:147–209

    Article  CAS  PubMed  Google Scholar 

  3. Schlenker EH (2012) Effects of hypothyroidism on the respiratory system and control of breathing human studies and animal models. Respir Physiol Neurobiol 181:123–131

    Article  CAS  PubMed  Google Scholar 

  4. Koromilas C, Liapi C, Schulpis KH, Kalafatakis K, Zarros A, Tsakiris S (2010) Structural and functional alterations in the hippocampus due to hypothyroidism. Metab Brain Dis 25:339–354

    Article  CAS  PubMed  Google Scholar 

  5. Ahmed OM, Abd El-Tawab SM, Ahmed RG (2010) Effects of experimentally induced maternal hypothyroidism and neurotransmitters and adenosinergic system interactions. Int J Dev Neurosci 28:437–454

    Article  CAS  PubMed  Google Scholar 

  6. Wang Y, Zhong J, Wei W, Gong J, Dong J, Yu F, Wang Y, Chen J (2011) Developmental iodine deficiency and hypothyroidism impair neural development, upregulate caveolin-1, and downregulate synaptophysin in rat hippocampus. Biol Trace Elem Res 144:1039–1049

    Article  CAS  PubMed  Google Scholar 

  7. Rugge B, Balshem H, Sehgal R, Relevo R, Gorman P, Helfand M (2011) Screening and treatment of subclinical hypothyroidism or hyperthyroidism. Rockville (MD): Agency for Healthcare Research and Quality (US). Report No.: 11(12)-EHC033-EF

  8. Kansagra S, McCudden C, Willis M (2010) The challenges and complexities of thyroid hormone replacement. Labmedicine 41:229–348

    Google Scholar 

  9. Saini V, Yadav A, Arora M, Arora S, Singh R, Bhattacharjee J (2012) Correlation of creatinine with TSH levels in overt hypothyroidism-A requirement for monitoring of renal function in hypothyroid patients. Clin Biochem 45:212–214

    Article  CAS  PubMed  Google Scholar 

  10. Mitrou P, Raptis SA, Dimitriadis G (2011) Thyroid disease in older people. Maturitas 70:5–9

    Article  PubMed  Google Scholar 

  11. Ogbera A, Kuku S, Dada O (2012) The metabolic syndrome in thyroid disease: a report from Nigeria. Indian J Endocrinol Metab 16:417–422

    Article  PubMed Central  PubMed  Google Scholar 

  12. Schlenker EH (2012) Effects of hypothyroidism on the respiratory system and control of breathing: human studies and animal models. Respir Physiol Neurobiol 181:123–131

    Article  CAS  PubMed  Google Scholar 

  13. Adrees M, Gibney J, El-Saeity N, Boran G (2009) Effects of 18 months of L-T4 replacement in women with subclinical hypothyroidism. Clin Endocrinol 71:298–303

    Article  CAS  Google Scholar 

  14. Santos SO, Loureiro SM, Alves IG, Jesus CS, Santos PR, Santos MR, Dias DP, Santana-Filho VJ, Badauê-Passos D Jr (2012) Experimental gestational hypothyroidism evokes hypertension in adult offspring rats. Auton Neurosci 170:36–41

    Article  CAS  PubMed  Google Scholar 

  15. Stagnaro-Green A (2011) Overt hyperthyroidism and hypothyroidism during pregnancy. Clin Obstet Gynecol 54:478–487

    Article  PubMed  Google Scholar 

  16. Gartner R (2009) Thyroid diseases in pregnancy. Curr Opin Obstet Gynecol 21:501–507

    Article  PubMed  Google Scholar 

  17. Ige SF, Akhigbe RE, Akinsemola OO (2011) Intrauterine programming and postnatal hypertension. Res J Obstet Gynecol 4:01–27

    Article  Google Scholar 

  18. Fowden AL, Forhead AJ (2009) Endocrine regulation of feto-placental growth. Horm Res 72:257–265

    Article  CAS  PubMed  Google Scholar 

  19. Chattergoon NN, Giraud GD, Louey S, Stork P, Fowden AL, Thornburg KL (2012) Thyroid hormone drives fetal cardiomyocyte maturation. FASEB J 26:397–408

    Article  CAS  PubMed  Google Scholar 

  20. Chowdhury AR, Mandal S, Mittra B, Sharma S, Mukhopadhyay S, Majumder HK (2008) Betulinic acid, a potent inhibitor of eukaryotic topoisomerase I: identification of the inhibitory step, the major functional group responsible and development of more potent derivatives. Med Sci Monit 8(7):BR254–BR265

    Google Scholar 

  21. Yogeeswari P, Sriram D (2005) Betulinic acid and its derivatives: a review on their biological properties. Curr Med Chem 12:657–666

    Article  CAS  PubMed  Google Scholar 

  22. Einzhammer DA, Xu ZQ (2004) Betulinic acid: a promising anticancer candidate. IDrugs 4:359–373

    Google Scholar 

  23. Domínguez-Carmona DB, Escalante-Erosa F, García-Sosa K, Ruiz-Pinell G, Gutierrez-Yapu D, Chan-Bacab MJ, Giménez-Turba A, Peña-Rodríguez LM (2010) Antiprotozoal activity of betulinic acid derivatives. Phytomedicine 17(5):379–382

    Article  PubMed  Google Scholar 

  24. Liu WK, Ho JC, Cheung FW, Liu BP, Ye WC, Che CT (2004) Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line. Eur J Pharmacol 498(1–3):71–78

    Article  CAS  PubMed  Google Scholar 

  25. Alakurtti S, Makela T, Koskimies S, Yli-Kauhaluoma J (2006) Pharmacological properties of the ubiquitous natural product betulin. Eur J Pharm Sci 29:1–13

    Article  CAS  PubMed  Google Scholar 

  26. Takada Y, Aggarwal BB (2003) Betulinic acid suppresses carcinogen-induced NF kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9. J Immunol 171:3278–3286

    CAS  PubMed  Google Scholar 

  27. Salvati S, Attorri L, Campeggi LM (1994) Effect of propylthiouracil-induced hypothyroidism on cerebral cortex of young and aged rats: lipid composition of synaptosomes, muscarinic receptor sites, and acetylcholinesterase activity. Neurochem Res 19:1181–1186

    Article  CAS  PubMed  Google Scholar 

  28. Cano-Europa E, Blas-Valdivia V, Franco-Colin M, Gallardo-Casas CA, Ortiz-Butrón R (2011) Methimazole-induced hypothyroidism causes cellular damage in the spleen, heart, liver, lung and kidney. Acta Histochem 113:1–5

    Article  CAS  PubMed  Google Scholar 

  29. Wan Y, Wu YL, Lian LH, Xie WX, Li X, Ouyang BQ, Bai T, Li Q, Yang N, Nan JX (2012) The anti-fibrotic effect of betulinic acid is mediated through the inhibition of NF-κB nuclear protein translocation. Chem Biol Interact 195:215–223

    Article  CAS  PubMed  Google Scholar 

  30. Tousson E, Beltagy DM, El-Gerbed M, Gazia MA, Mohamed A (2012) The ameliorating role of folic acid in rat hippocampus after propylthiouracil-induced hypothyroidism. Biomed Aging Pathol 2:104–110

    Article  CAS  Google Scholar 

  31. Cooper DS (2000) Treatment of thyrotoxicosis. In: Bravermann LE, Utiger RD (eds) Werner & Ingbar’s, The Thyroid. A fundamental and clinical text, 8th edn. Lippincott Williams & Wilkins, Philadelphia, pp 691–715

    Google Scholar 

  32. Taurog A (1976) The mechanism of action of thioureylene antithyroid drugs. Endocrinology 98:1031–1046

    Article  CAS  PubMed  Google Scholar 

  33. Salminen A, Lehtonen M, Suuronen T, Kaarniranta K, Huuskonen J (2008) Terpenoids: natural inhibitors of NF-kappa B signaling with anti-inflammatory and anticancer potential. Cell Mol Life Sci 65:2979–2999

    Article  CAS  PubMed  Google Scholar 

  34. Ness GC, Lopez D, Chambers CM, Newsome WP, Cornelius P, Long CA, Harwood HJ Jr (1998) Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression. Biochem Pharmacol 56:121–129

    Article  CAS  PubMed  Google Scholar 

  35. Ness GC, Lopez D (1995) Transcriptional regulation of rat hepatic low-density lipoprotein receptor and cholesterol 7 alpha hydroxylase by thyroid hormone. Arch Biochem Biophys 323:404–408

    Article  CAS  PubMed  Google Scholar 

  36. Taylor AH, Stephan ZF, Steele RE, Wong NC (1997) Beneficial effects of a novel thyromimetic on lipoprotein metabolism. Mol Pharmacol 52:542–547

    CAS  PubMed  Google Scholar 

  37. Malik R, Hodgson H (2002) The relationship between the thyroid gland and the liver. QJM 95(9):559–569

    Article  CAS  PubMed  Google Scholar 

  38. Yi JE, Obminska-Mrukowicz B, Yuan LY, Yuan H (2010) Immunomodulatory effects of betulinic acid from the bark of white birch on mice. J Vet Sci 11:305–313

    Article  PubMed Central  PubMed  Google Scholar 

  39. Lluberas-Acosta G, Schumacher HRJ (1996) Markedly elevated erythrocyte sedimentation rates: consideration of clinical implications in a hospital population. Br J Clin Pract 50:138–142

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Imran Kazmi or Firoz Anwar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Afzal, M., Kazmi, I., Semwal, S. et al. Therapeutic exploration of betulinic acid in chemically induced hypothyroidism. Mol Cell Biochem 386, 27–34 (2014). https://doi.org/10.1007/s11010-013-1842-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-013-1842-0

Keywords

Navigation